Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Korro Bio, Inc. (KRRO) had Weighted-Average Shares Outstanding (Diluted) of 11.60M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-19.62M |
|
-- |
|
-- |
|
$20.44M |
|
$-20.44M |
|
$0.91M |
|
$-19.53M |
|
$-19.53M |
|
$-19.62M |
|
$-19.62M |
|
$-19.62M |
|
$-19.62M |
|
$-20.44M |
|
$-20.05M |
|
11.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
11.60M |
$-1.69 |
|
$-1.69 |
|
| Balance Sheet Financials | |
$120.16M |
|
$7.80M |
|
$63.46M |
|
$183.62M |
|
$14.79M |
|
-- |
|
$49.20M |
|
$63.99M |
|
$119.63M |
|
$119.63M |
|
$119.63M |
|
14.42M |
|
| Cash Flow Statement Financials | |
$-16.07M |
|
$-32.24M |
|
$88.21M |
|
$25.23M |
|
$65.10M |
|
$39.87M |
|
$2.73M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-16.09M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.40% |
|
-16.40% |
|
-10.69% |
|
-16.40% |
|
$8.29 |
|
$-1.39 |
|
$-1.39 |
|